by Holly Roenicke | Apr 18, 2024 | April 2024, Home Page Featured Story, News
AXIA ARTICLE April 18, 2024 Print Version (PDF) The Urgent Need for Connected Labels in Ensuring Our Safety In light of recent events involving counterfeit Botox, the looming threat of fake drugs presents a grave danger to public health. With the FDA sounding the...
by Holly Roenicke | Apr 11, 2024 | April 2024, Home Page Featured Story, News
AXIA ARTICLE April 11, 2024 Print Version (PDF) Digitization Changed How We Drive. Are Connected Drug Labels Next? In today’s tech-driven world, connected cars steal the spotlight with autonomous driving and an impressive array of safety features as they...
by Holly Roenicke | Apr 4, 2024 | April 2024, Home Page Featured Story, News
AXIA ARTICLE March 2024 Print Version (PDF) Revolutionizing Access to Drug Information: the Case for e-Labeling In today’s fast-paced digital world, where information is readily accessible at a patient’s fingertips, why should accessing critical information...
by Holly Roenicke | Mar 21, 2024 | Home Page Featured Story, March 2024, News, Research Items
March 2024 In August 2023, the Axia Institute began connecting stakeholders in the pharmaceutical value chain to identify the challenges of the current landscape and collaborate on opportunities to find efficiencies in the supply chain and possibly improve patient...
by Holly Roenicke | Oct 11, 2023 | Events, Home Page Featured Story, October 2023
Launch of RFID Executive Education Course October 2023 Radio Frequency Identification or RFID is a leading identification technology with traceability applications across industries. To help you better understand this fast-evolving technology, your partners at the...
Recent Comments